首页> 外文期刊>Journal of Pharmaceutical Analysis >Herb-drug interaction in the protective effect of Alpinia officinarum against gastric injury induced by indomethacin based on pharmacokinetic, tissue distribution and excretion studies in rats
【24h】

Herb-drug interaction in the protective effect of Alpinia officinarum against gastric injury induced by indomethacin based on pharmacokinetic, tissue distribution and excretion studies in rats

机译: alpinia Officinarum的保护作用中的药物 - 药物 - 斜视>基于药代动力学,组织分布和排泄研究的吲哚美辛诱导的胃损损伤

获取原文
获取外文期刊封面目录资料

摘要

Alpinia officinarumHance of the Chinese traditional herb for the treatment of emesis, abdominal pain and diarrhea has been used to counteract gastric disease induced by indomethacin in rats without obvious side effects. However, the role of herb-drug interaction between indomethacin andA.?officinarumbased on pharmacokinetic, tissue distribution and excretion still remains unknown. In this study, an ultra-fast liquid-tandem mass spectrometry (UFLC-MS/MS) method was developed for simultaneous determination of indomethacin and its three metabolites, O-desmethylindomethacin (ODI), deschlorobenzoylindomethacin (NDI) and indomethacin acyl-β-D-glucuronide (IDAβG) by oral administration of indomethacin solution with and without the ethanolic extract ofA.?officinarumand applied to comparative pharmacokinetic, tissue distribution and excretion studies. Our results clarified that oral administration ofA.?officinarumproduced significant alterations in the pharmacokinetic parameters of indomethacin. And the pharmacokinetic interaction between indomethacin andA.?officinarumreduced the systemic exposure of indomethacin and increased its elimination. Tissue distribution results demonstrated that co-administration ofA.?Officinarumcould not reduce the accumulation of indomethacin in the target tissue of the stomach, but could accelerate the excretions of indomethacin and its three metabolites including ODI, NDI and IDAβG in the bile and feces of rats in the excretion study. Therefore,A.?Officinarummight have a gastrointestinal protective effect through the interaction role with indomethacin based on the pharmacokinetics and excretion in rats.
机译:阿尔卑斯岛官方Humhance用于治疗呕吐,腹痛和腹泻的治疗,已被用于抵消诱导吲哚美辛诱导的胃病,而无明显副作用。然而,在吲哚美嗪和诱导的药代动力学,组织分布和排泄之间的吲哚美辛和排泄之间的作用仍然未知。在该研究中,开发了超快速液体串联质谱(UFLC-MS / MS)方法,用于同时测定吲哚美辛及其三种代谢物,O-去甲基吲哚(ODI),Deschorroboylinomethacin(NDI)和吲哚美辛酰基-β- - 通过口服吲哚美嗪溶液(IDAβG)与乙醇提取物的吲哚美辛溶液的口服施用,用于应用于对比药代动力学,组织分布和排泄研究。我们的结果澄清了口服给药.?OFFICINARUMARUMPRODUED在吲哚美辛的药代动力学参数中的显着改变。和吲哚美辛和AA的药代动力学相互作用.?OFFICINARUMARUMUED诱导吲哚美辛的全身暴露并增加了消除。组织分布结果表明,共同施用.?Officinarumcould不会减少胃部靶组织中吲哚美辛的积累,但可以加速吲哚美辛的排泄及其三种代谢物,包括胆汁和粪便中的odi,ndi和idaβg,包括大鼠和粪便在排泄研究中。因此,a。officinarummight通过基于大鼠药代动力学和排泄的吲哚美辛与吲哚美辛的相互作用作用具有胃肠道保护作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号